LeMaitre Vascular, Inc. (LMAT) Q4 2018 Earnings Results

Lemaitre Vascular Inc Beats on EPS, Stock Down 0.2%

Lemaitre Vascular's earnings report shows a solid EPS beat, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.2%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.30	N/A	+33.93%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook on their product performance. However, they did not provide specific guidance for future quarters.

Management highlighted strong performance in key product lines.

They expressed confidence in maintaining growth despite market challenges.

Lemaitre Vascular Inc Beats on EPS, Stock Down 0.2%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Inc Beats on EPS, Stock Down 0.2%

Key numbers

Management commentary